{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T22:48:34Z","timestamp":1775515714968,"version":"3.50.1"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,5,28]]},"DOI":"10.1001\/jama.2024.5713","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T15:32:43Z","timestamp":1714663963000},"page":"1767","source":"Crossref","is-referenced-by-count":2,"title":["Recurrent Gout and Serum Urate"],"prefix":"10.1001","volume":"331","author":[{"given":"Kuochen","family":"Chang","sequence":"first","affiliation":[{"name":"Anesthesiology, Far Eastern Memorial Hospital, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunfa","family":"Hung","sequence":"additional","affiliation":[{"name":"Anesthesiology, Far Eastern Memorial Hospital, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"5","key":"jle240048r1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jama.2023.26640","article-title":"Serum urate and recurrent gout.","volume":"331","author":"McCormick","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"jle240048r2","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","article-title":"British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.","volume":"46","author":"Jordan","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"10156","key":"jle240048r3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"jle240048r4","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/rheumatology\/key155","article-title":"Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD).","volume":"57","author":"Scheepers","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"jle240048r5","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","article-title":"Gout: why is this curable disease so seldom cured?","volume":"71","author":"Doherty","year":"2012","journal-title":"Ann Rheum Dis"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2818359\/jama_chang_2024_le_240048_1716416476.2054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T17:58:19Z","timestamp":1716919099000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2818359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":5,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,5,28]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.5713","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}